Polypharmacy in elderly patients

American Journal Geriatric Pharmacotherapy

Volumn 5, Issue 4, 2007, Pages 345-351

  Hajjar, Emily R ^a   Cafiero, Angela C ^b   Hanlon, Joseph T ^c,d  

^a UNIVERSITY OF THE SCIENCES   (United States)

^b ABBOTT LABORATORIES   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

morbidity; mortality; older adults; polypharmacy

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANALGESIC AGENT; ANTACID AGENT; ANTIBIOTIC AGENT; ANTILIPEMIC AGENT; ASCORBIC ACID; ATORVASTATIN; CARDIOVASCULAR AGENT; DIPHENHYDRAMINE; DIURETIC AGENT; ESTROGEN DERIVATIVE; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; HERBACEOUS AGENT; HYDROCHLOROTHIAZIDE; IBUPROFEN; LAXATIVE; LEVOTHYROXINE; LISINOPRIL; MINERAL; MULTIVITAMIN; OPIATE DERIVATIVE; PARACETAMOL; PSEUDOEPHEDRINE; VITAMIN; WARFARIN;

AGED; ARTICLE; DRUG UTILIZATION; ELDERLY CARE; EPIDEMIOLOGICAL DATA; HEALTH CARE PERSONNEL; HUMAN; MEDLINE; MORBIDITY; MORTALITY; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; POLYPHARMACY; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR;

AGE FACTORS; AGED; DRUG TOXICITY; HUMANS; MEDICATION ERRORS; PHYSICIAN'S PRACTICE PATTERNS; POLYPHARMACY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 37548998920     PISSN: 15435946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2007.12.002     Document Type: Article

References (59)

1. Federal Interagency Forum on Aging-Related Statistics. Older Americans Update 2006: Key Indicators of Well-Being (May 2006), US Government Printing Office, Washington, DC
2. Gurwitz J. Polypharmacy: A new paradigm for quality drug therapy in the elderly?. Arch Intern Med 164 (2004) 1957-1959
3. Stewart R. Polypharmacy in the elderly: A fait accompli?. DICP 24 (1990) 321-323
4. Montamat S., and Cusack B. Overcoming problems with polypharmacy and drug misuse in the elderly. Clin Geriatr Med 8 (1992) 143-158
5. Stewart R., and Cooper J. Polypharmacy in the aged. Practical solutions. Drugs Aging 4 (1994) 449-461
6. Nolan L., and O'Malley K. Prescribing for the elderly. Part I: Sensitivity of the elderly to adverse drug reactions. J Am Geriatr Soc 36 (1988) 142-149
7. Nolan L., and O'Malley K. Prescribing for the elderly: Part II. Prescribing patterns: Differences due to age. J Am Geriatr Soc 36 (1988) 245-254
8. Frazier S. Health outcomes and polypharmacy in elderly individuals: An integrated literature review. J Gerontol Nurs 31 (2005) 4-11
9. Fulton M., and Allen E. Polypharmacy in the elderly: A literature review. J Am Acad Nurse Pract 17 (2005) 123-132
10. Aronson J. In defence of polypharmacy. Br J Clin Pharmacol 57 (2004) 119-120
11. Rollason V., and Vogt N. Reduction of polypharmacy in the elderly: A systematic review of the role of the pharmacist. Drugs Aging 20 (2003) 817-832
12. Guay D., Artz M., Hanlon J., and Schmader K. The pharmacology of aging. In: Tallis R., and Fillit H. (Eds). Brocklehurst's Textbook of Geriatric Medicine and Gerontology. 6th ed (2003), Churchill Livingstone, London, England 155-161
13. Hajjar E., and Hanlon J. Polypharmacy in the elderly. In: Calhoun K., Kost K., Wax M., and Eibling D. (Eds). Geriatric Medicine in Otolaryngology (2006), Informa Healthcare, London, England 667-673
14. Bjerrum L., Sogaard J., Hallas J., and Kragstrup J. Polypharmacy: Correlations with sex, age and drug regimen. A prescription database study. Eur J Clin Pharmacol 54 (1998) 197-202
15. Thomas H., Sweetnam P., Janchawee B., and Luscombe D. Polypharmacy among older men in South Wales. Eur J Clin Pharmacol 55 (1999) 411-415
16. Fialova D., Topinkova E., Gambassi G., et al., for the AdHOC Project Research Group. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 293 (2005) 1348-1358
17. Linjakumpu T., Hartikainen S., Klaukka T., et al. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol 55 (2002) 809-817
18. Cannon K., Choi M., and Zuniga M. Potentially inappropriate medication use in elderly patients receiving home health care: A retrospective data analysis. Am J Geriatr Pharmacother 4 (2006) 134-143
19. Denneboom W., Dautzenberg M., Grol R., and De Smet P. Analysis of polypharmacy in older patients in primary care using a multidisciplinary expert panel. Br J Gen Pract 56 (2006) 504-510
20. Zarowitz B., Stebelsky L., Muma B., et al. Reduction of high-risk polypharmacy drug combinations in patients in a managed care setting. Pharmacotherapy 25 (2005) 1636-1645
21. Hanlon J., Fillenbaum G., Burchett B., et al. Drug-use patterns among black and nonblack community-dwelling elderly. Ann Pharmacotber 26 (1992) 679-685
22. Roth M., and Ivey J. Self-reported medication use in community-residing older adults: A pilot study. Am J Geriatr Pharmacother 3 (2005) 196-204
23. Kaufman D., Kelly J., Rosenberg L., et al. Recent patterns of medication use in the ambulatory adult population of the United States: The Slone survey. JAMA 287 (2002) 337-344
24. Stoehr G., Ganguli M., Seaberg E., et al. Over-the-counter medication use in an older rural community: The MoVIES Project. J Am Geriatr Soc 45 (1997) 158-165
25. Gurwitz J., Field T., Harrold L., et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 289 (2003) 1107-1116
26. Lipton H., Bero L., Bird J., and McPhee S. The impact of clinical pharmacists' consultations on physicians' geriatric drug prescribingA randomized controlled trial. Med Care 30 (1992) 646-658
27. Schmader K., Hanlon J., Weinberger M., et al. Appropriateness of medication prescribing in ambulatory elderly patients. J Am Geriatr Soc 42 (1994) 1241-1247
28. Schmader K., Hanlon J., Pieper C., et al. Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med 116 (2004) 394-401
29. Hajjar E., Hanlon J., Sloane R., et al. Unnecessary drug use in frail older people at hospital discharge. J Am Geriatr Soc 53 (2005) 1518-1523
30. Steinman M., Landefeld C., Rosenthal G., et al. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc 54 (2006) 1516-1523
31. Chrischilles E., Foley D., Wallace R., et al. Use of medications by persons 65 and over: Data from the established populations for epidemiologic studies of the elderly. J Gerontol 47 (1992) M137-M144
32. Fillenbaum G., Homer R., Hanlon J., et al. Factors predicting change in prescription and nonprescription drug use in a community-residing black and white elderly population. J Clin Epidemiol 49 (1996) 587-593
33. Espino D., Lichtenstein M., Hazuda H., et al. Correlates of prescription and over-the-counter medication usage among older Mexican Americans: The Hispanic EPESE study (Established Population for the Epidemiologic Study of the Elderly). J Am Geriatr Soc 46 (1998) 1228-1234
34. Jorgensen T., Johansson S., Kennerfalk A., et al. Prescription drug use, diagnoses, and healthcare utilization among the elderly. Ann Pharmacother 35 (2001) 1004-1009
35. Ryan A. Medication compliance and older people: A review of the literature. Int J Nurs Stud 36 (1999) 153-162
36. Lipton H., and Bird J. The impact of clinical pharmacists' consultations on geriatric patients' compliance and medical care use: A randomized controlled trial. Gerontologist 34 (1994) 307-315
37. Benner J., Glynn R., Mogun H., et al. Long term persistence in the use of statin therapy in elderly patients. JAMA 288 (2002) 455461
38. German P., Klein L., McPhee S., and Smith C. Knowledge of and compliance with drug regimens in the elderly. J Am Geriatr Soc 30 (1982) 568-571
39. Hanlon J., Artz M., Pieper C., et al. Inappropriate medication use among frail elderly inpatients. Ann Pharmacother 38 (2004) 9-14
40. Venulet J., and ten Ham M. Methods for monitoring and documenting adverse drug reactions. Int J Clin Pharmacol Ther 34 (1996) 112-129
41. Hanlon J., Schmader K., and Gray S. Adverse drug reactions. In: Delafuente J., and Stewart R. (Eds). Therapeutics in the Elderly. 3rd ed (2001), Harvey Whitney Books, Cincinnati, Ohio 289-314
42. Gray S., Mahoney J., and Blough D. Adverse drug events in elderly patients receiving home health services following hospital discharge. Ann Pharmacother 33 (1999) 1147-1153
43. Grymonpre R., Mitenko P., Sitar D., et al. Drug-associated hospital admissions in older medical patients. J Am Geriatr Soc 36 (1988) 1092-1098
44. Hanlon J., Pieper C., Hajjar E., et al. Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay. J Gerontol A Biol Sci Med Sci 61 (2006) 511-515
45. Nguyen J., Fouts M., Kotabe S., and Lo E. Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents. Am J Geriatr Pharmacother 4 (2006) 36-41
46. Larson E., Kukull W., Buchner D., and Reifler B. Adverse drug reactions associated with global cognitive impairment in elderly persons. Ann Intern Med 107 (1987) 169-173
47. Ruby C., Hanlon J., Fillenbaum G., et al. Medication use and control of urination among community-dwelling older adults. J Aging Health 17 (2005) 661-674
48. Fink H., Wyman J., and Hanlon J. Falls. In: Tallis R., and Fillit H. (Eds). Brocklehurst's Textbook of Geriatric Medicine and Gerontology. 6th ed (2003), Churchill Livingstone, London, England 1337-1346
49. Agostini J., Han L., and Tinetti M. The relationship between number of medications and weight loss or impaired balance in older adults. J Am Geriatr Soc 52 (2004) 1719-1723
50. Weiner D., Hanlon J., and Studenski S. Effects of central nervous system polypharmacy on falls liability in community-dwelling elderly. Gerontology 44 (1998) 217-221
51. Magaziner J., Cadigan D., Fedder D., and Hebel J. Medication use and functional decline among community dwelling older women. J Aging Health 1 (1989) 470-484
52. Espino D., Bazaldua O., Palmer R., et al. Suboptimal medication use and mortality in an older adult community-based cohort: Results from the Hispanic EPESE Study. J Gerontol A Biol Sci Med Sci 61 (2006) 170-175
53. Masoudi F., Baillie C., Wang Y., et al. The complexity and cost of drug regimens of older patients hospitalized with heart failure in the United States, 1998-2001. Arch Intern Med 165 (2005) 2069-2076
54. Fillit H., Futterman R., Orland B., et al. Polypharmacy management in Medicare managed care: Changes in prescribing by primary care physicians resulting from a program promoting medication reviews. Am J Manag Care 5 (1999) 587-594
55. Fick D., Maclean J., Rodriguez N., et al. A randomized study to decrease the use of potentially inappropriate medications among community-dwelling older adults in a southeastern managed care organization. Am J Manag Care 10 (2004) 761-768
56. Muir A., Sanders L., Wilkinson W., and Schmader K. Reducing medication regimen complexity. A controlled trial. J Gen Intern Med 16 (2004) 77-82
57. Murray M., Darnell J., Weinberger M., and Martz B. Factors contributing to medication noncompliance in elderly public housing tenants. Drug Intell Clin Pharm 20 (1986) 146-152
58. Murray M., Birt J., Manatunga A., and Darnell J. Medication compliance in elderly outpatients using twice-daily dosing and unit-of-use packaging. Ann Pharmacother 27 (1993) 616-621
59. Cramer J. Enhancing patient compliance in the elderly. Role of packaging aids and monitoring. Drugs Aging 12 (1998) 7-15